PSC subtyping based on TTF-1 and p40 expression reveals distinct molecular characteristics and therapeutic strategies.
Yang Z, Tian H, Li L, Li C, Xu J, Bie F, Chen Y, Tian Y, Bai G, Peng Y, Yang J, Fan T, Xiao C, Liu W, Liu L, Li R, Sun S, Zheng B, Tan F, Ying J, Li C, Gao S, He J.
Yang Z, et al.
Int J Cancer. 2022 Sep 1;151(5):717-729. doi: 10.1002/ijc.34137. Epub 2022 Jun 8.
Int J Cancer. 2022.
PMID: 35612583
Free article.